A. Heidenreich Et Al. , "Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme," EUROPEAN JOURNAL OF CANCER , vol.50, no.6, pp.1090-1099, 2014
Heidenreich, A. Et Al. 2014. Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme. EUROPEAN JOURNAL OF CANCER , vol.50, no.6 , 1090-1099.
Heidenreich, A., Bracarda, S., Mason, M., Ozen, H., Sengelov, L., Van Oort, I., ... Papandreou, C.(2014). Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme. EUROPEAN JOURNAL OF CANCER , vol.50, no.6, 1090-1099.
Heidenreich, Axel Et Al. "Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme," EUROPEAN JOURNAL OF CANCER , vol.50, no.6, 1090-1099, 2014
Heidenreich, Axel Et Al. "Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme." EUROPEAN JOURNAL OF CANCER , vol.50, no.6, pp.1090-1099, 2014
Heidenreich, A. Et Al. (2014) . "Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme." EUROPEAN JOURNAL OF CANCER , vol.50, no.6, pp.1090-1099.
@article{article, author={Axel Heidenreich Et Al. }, title={Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme}, journal={EUROPEAN JOURNAL OF CANCER}, year=2014, pages={1090-1099} }